Applied DNA Reports Third Quarter Fiscal 2022 Financial Results
August 11th, 2022
News
All Categories
ACDL
APDN in the News
CertainT®
Coronavirus
Corporate/Financial News
Investors
Large-Scale DNA Production
Linear DNA
mpox
PGx
Press Release
Uncategorized
Vaccines
First Successful Administration of LinearDNA via Lipid Nanoparticles
August 10th, 2022
APDN Awarded Extension of Health Services Contract with CUNY
August 9th, 2022
APDN Receives ~$3.6 Million in Net Proceeds from Warrant Exercise
August 9th, 2022
APDN to Host Conference Call and Webcast Discussing FQ3’22 Results
August 8th, 2022
APDN Announces Closing of $12M Upsized Public Offering
August 8th, 2022
APDN Announces Pricing of $12M Upsized Public Offering
August 4th, 2022
APDN Initiates Validation of PCR-based Monkeypox Diagnostic Test
August 2nd, 2022
LineaRx, EvviVax Publish Additional Positive Animal Proof-of-Concept Data
July 25th, 2022